SCHEMBL20765935

SCHEMBL20765935

CCOC(=O)C1=C(NCc2ccc(C)cc2)CCN(C(=O)OC(C)(C)C)C1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
CYP2C19 P33261 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
ADORA1 P30542 1/20 0.45
ALDH1A1 P00352 2/20 0.41
NPSR1 Q6W5P4 2/20 0.40
TSHR P16473 1/20 0.40
CASP3 P42574 3/20 0.40
ESR2 Q92731 1/20 0.39
TP53 P04637 1/20 0.39
GPR119 Q8TDV5 1/20 0.39
NR1H2 P55055 1/20 0.39
ACHE P22303 1/20 0.39
LMNA P02545 1/20 0.38
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5727368 0.92 CASP3 (0.49) KMT2AMEN1SMN1; SMN2ADORA1NPSR1
SCHEMBL17629577 0.90 MAPT (0.42) KMT2AMEN1CYP2C19SMN1; SMN2ADORA1
SCHEMBL1586711 0.84 CASP3 (0.49) KMT2AMEN1SMN1; SMN2ADORA1NPSR1
SCHEMBL6304400 0.82 ACHE (0.49) CASP3ESR2GPR119NR1H2ACHE
SCHEMBL13488441 0.82 CXCR3 (0.43) KMT2AMEN1SMN1; SMN2ADORA1ALDH1A1
SCHEMBL13488374 0.81 ALDH1A1 (0.49) KMT2AMEN1SMN1; SMN2ADORA1ALDH1A1
SCHEMBL14920289 0.80 CHRM5 (0.50) ADORA1ESR2GPR119NR1H2
SCHEMBL5927238 0.79 ADORA1 (0.46) KMT2AMEN1SMN1; SMN2ADORA1ALDH1A1
SCHEMBL6868401 0.76 ADORA1 (0.56) KMT2AMEN1SMN1; SMN2ADORA1ALDH1A1
SCHEMBL21047249 0.76 ADORA1 (0.43) KMT2AMEN1ADORA1TSHRESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019040106-A2 COMPOUNDS, SALTS THEREOF AND METHODS FOR TREATMENT OF DISEASES ACADIA PHARMACEUTICALS INC. (US) 2019-02-28 WO disclosed